VC  HealthCare Ventures

http://www.hcven.com





     Office Locations:

47 Thorndike Street, SuiteB1-1
Cambridge, MA 02141
Phone: 617-252-4343

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Founded 1985, HealthCare Ventures (HCV) is a venture capital firm specializing in life science industry investing. The firm's target sectors include: target-focused cancer, infectious disease, cardiovascular disease, central nervous system disorders, immunomodulation and immunotherapy, novel manufacturing technologies, and novel lab scale instruments and reagents. The firm has raised over $1.6 billion in capital and has managed nine funds over the past twenty-five years. The fund's typical initial investments range between $1 million to $20 million in the form of equity or debt convertible to equity. HCV has invested in a total of 106 companies, 68 of which were start-ups.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Augustine Lawlor Managing Director
    Christopher K. Mirabelli Ph.D. Managing Director
    Douglas E. Onsi Venture Partner
    Harold R. Werner Co-Founder
    James H. Cavanaugh Ph.D. Managing Director

     

    Portfolio companies include:


      Aciex
        web link


      Anexon
        web link


      Antisoma
        web link


      Apellis Pharmaceuticals
        web link


      Apofore
        web link


      Arresto BioSciences
        web link


      Ascent Therapeutics
        web link


      Bikam Pharmaceuticals
        web link


      Cardiokine
        web link


      Cellnovo Systems
        web link


      Cleveland HeartLab
        web link


      Colorescience
        web link


      DecImmune Therapeutics
        web link


      Dekkun
        web link


      FoldRx
        web link


      Galleon Pharmaceuticals
        web link


      GITR Inc
        web link


      GlobeImmune
        web link


      InfaCare Pharmaceutical
        web link


      Mosaic Biosciences
        web link


      nanoMR
        web link


      PathoGenetix
        web link


      PharmAthene
        web link


      Promedior
        web link


      Radius Health
        web link


      Seahorse Bioscience
        web link


      Senseonics
        web link


      SkinMedica
        web link


      Stemgent
        web link


      Synovex
        web link


      Tetra Logic Pharmaceuticals
        web link


      Theraclone Sciences
        web link


      Threshold Pharmaceuticals
        web link


      Tolerx
        web link


      Treneva
        web link


      Vaxinnate
        web link


      Vaxxas
        web link


      Xencor
        web link


     

    Recent News:


      There is no recent news for HealthCare Ventures.